Providers who participate in the Competitive Acquisition Program—the program that allows CMS to select vendors who fill physician orders for drugs and other pharmaceuticals—can no longer report modifier -JW to receive reimbursement for unused vials, according to Transmittal R1478CP, effective April 14. Susan Garrison, CPC, CPC-H, CCS-P, CPAR, explains the modifier.